Status:

UNKNOWN

Cladribine Dose Escalation in Conditioning Regimen Prior to Allo-HSCT for Refractory Acute Leukemia and Myelodysplastic Syndromes

Lead Sponsor:

Institut Paoli-Calmettes

Conditions:

Leukemia, Myeloid, Acute

Leukemia, Lymphoblastic, Acute

Eligibility:

All Genders

18-70 years

Phase:

PHASE1

Brief Summary

The investigators focused on patients with refractory acute leukemia or MDS and designed a phase 1 trial of escalated cladribine doses in the Cla-Flu-Bu RTC regimen using PK-guided myeloablative busul...

Eligibility Criteria

Inclusion

  • Age 18-70
  • ECOG 0 or 1
  • Acute leukemia (AML or ALL) without criteria for CR or high risk MDS without criteria for CR
  • Availability of a donor among following oHLA identical sibling oHaploidentical donor o10/10 or 9/10 allele-level HLA matched unrelated donor
  • Signed informed consent
  • Patient affiliated to the national "Social Security" regimen or beneficiary of this regimen

Exclusion

  • Contraindication for Allo-HSCT
  • Cord blood Allo-HSCT
  • Current active disease or positive serology for HIV, and/or HCV with detectable viremia and/ or HBV with positive Hbs Antigen.
  • Renal failure with creatinine clearance \< 30 ml/ min
  • Decompensated haemolytic anaemia
  • Hypersensitivity to an active substance or to any of the excipients
  • Acute urinary infection
  • Pre-existing haemorrhagic cystitis
  • Woman of childbearing potential not using an effective contraception .
  • Pregnant or lactating women
  • Any serious concurrent uncontrolled medical disorder
  • Any psychological, familial, sociological or geographical condition potentially hampering compliance with the study protocol and follow-up schedule.

Key Trial Info

Start Date :

April 28 2018

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

April 1 2021

Estimated Enrollment :

29 Patients enrolled

Trial Details

Trial ID

NCT03235973

Start Date

April 28 2018

End Date

April 1 2021

Last Update

June 28 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Institut Paoli-Calmettes

Marseille, Bouches-du-Rhône, France, 13009